Adlai Nortye (ANL) Other Accumulated Expenses (2023 - 2025)
Adlai Nortye (ANL) reported Other Accumulated Expenses of $4.9 million for Q2 2025, up 28.73% year-over-year from $3.8 million in Q2 2024, and up 42.95% on a QoQ basis from $3.4 million in Q4 2024.
Adlai Nortye (ANL) has 3 years of Other Accumulated Expenses data on file, last reported at $4.9 million in Q2 2025.
- Quarterly Other Accumulated Expenses rose 28.73% year-over-year to $4.9 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $4.9 million (up 28.73% YoY) and the FY2024 annual result came in at $3.4 million, down 30.2% from the prior year.
- Other Accumulated Expenses improved to $4.9 million in Q2 2025 per ANL's latest filing, from $3.4 million in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $4.9 million in Q4 2023 and bottomed at $3.4 million in Q4 2024.
- The 3-year median for Other Accumulated Expenses is $4.3 million (2024), against an average of $4.2 million.
- The widest annual swing landed in 2024, when Other Accumulated Expenses tumbled 30.2%; it then increased 28.73% in 2025.
- Tracing ANL's Other Accumulated Expenses over 3 years: stood at $4.9 million in 2023, then plunged by 30.2% to $3.4 million in 2024, then soared by 42.95% to $4.9 million in 2025.
- Per Business Quant, the three latest ANL Other Accumulated Expenses figures stand at $4.9 million (Q2 2025), $3.4 million (Q4 2024), and $3.8 million (Q2 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn |
| 10 | Adlai Nortye | 23,840.00 | -8.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 4.88 Mn |
| Dec 31, 2024 | 3.41 Mn |
| Jun 30, 2024 | 3.79 Mn |
| Dec 31, 2023 | 4.89 Mn |